Golden Dayz / Shutterstock.com

16 January 2025NewsEuropeLiz Hockley

EPO report reveals leading tech investors in Europe

New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Takeda loses AMR treatment patent used in kidney transplants

9 January 2025 Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data.

Tissue repair VP gets new trial over secrets damages

7 January 2025 Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.

More on this story

Takeda loses AMR treatment patent used in kidney transplants

9 January 2025 Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data.

Tissue repair VP gets new trial over secrets damages

7 January 2025 Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.

More on this story

Takeda loses AMR treatment patent used in kidney transplants

9 January 2025 Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data.

Tissue repair VP gets new trial over secrets damages

7 January 2025 Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.

More features

Novartis stops rival’s launch of Entresto generic

Maucher Jenkins lands nine-strong team from rival boutique

K&L Gates adds litigator in Melbourne

Gowling WLG’s legal director jumps to Osborne Clarke

Novartis wins appeal in MSN clash over heart drug generic

Takeda loses AMR treatment patent used in kidney transplants

Withers & Rogers hires cell and gene therapy expert

Medtech firm strikes out part of Apple button patent in ECG row